Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome‐positive leukemias with the T315I mutation

BACKGROUND: Effective treatment options for patients with chronic myeloid leukemia (CML) or Philadelphia‐positive (Ph+) acute lymphoblastic leukemia (ALL) who have the threonine to isoleucine mutation at codon 315 (T315I) are few. The objective of this study was to compare overall survival (OS) betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolini, Franck E., Basak, Grzegorz W., Kim, Dong‐Wook, Olavarria, Eduardo, Pinilla‐Ibarz, Javier, Apperley, Jane F., Hughes, Timothy, Niederwieser, Dietger, Mauro, Michael J., Chuah, Charles, Hochhaus, Andreas, Martinelli, Giovanni, DerSarkissian, Maral, Duh, Mei Sheng, McGarry, Lisa J., Kantarjian, Hagop M., Cortes, Jorge E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573914/
https://www.ncbi.nlm.nih.gov/pubmed/28387926
http://dx.doi.org/10.1002/cncr.30558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573914/
https://www.ncbi.nlm.nih.gov/pubmed/28387926
http://dx.doi.org/10.1002/cncr.30558

Ejemplares similares